Landec Corporation Schedules Second Quarter 2013 Earnings Release for January 2, 2013 and Conference Call for January 3, 2013

Landec Corporation Schedules Second Quarter 2013 Earnings Release for January
2, 2013 and Conference Call for January 3, 2013

MENLO PARK, Calif., Dec. 12, 2012 (GLOBE NEWSWIRE) -- Landec Corporation
(Nasdaq:LNDC) announced today that it will report financial results for the
fiscal year 2013 second quarter ended November 25, 2012, after market close on
Wednesday, January 2, 2013.

The news release will be followed the next morning, Thursday, January 3, 2013,
by a teleconference and webcast open to all interested parties at 8:00 a.m.,
Pacific Time. The teleconference can be accessed by calling (866) 244-4637 or
(703) 639-1179. Please log in 5 - 10 minutes prior to the beginning of the
call.

This call is being webcast and can be accessed at Landec's web site at
www.Landec.com/earningscall. The webcast will be available for 30 days through
February 2, 2013. A replay of the teleconference will be available for one
week until midnight Eastern Time, Thursday, January 10, 2013, by calling
888-266-2081 or 703-925-2533. The access code for the replay is 1600693.

For further information, please call Greg Skinner (650) 261-3677.

Landec Corporation is a materials science company that leverages its
proprietary polymer technologies, application development and innovation
capabilities to develop and commercialize new products in food and
biomaterials markets. Landec has two proprietary polymer technology
platforms:Intelimer Polymers^®andHyaluronan ("HA") that are the foundation
for its business. Landec's subsidiary, Apio, has become the leader in US
fresh-cut specialty packaged vegetables sold in North America based on
combining Landec's proprietary food packaging technology and the strength of
two major national brands Eat Smart® and GreenLine®, with the capabilities of
a large national food supplier, processor and distributor. Through its
subsidiary, Lifecore Biomedical, Landec is a premium supplier of
hyaluronan-based materials and medical products to ophthalmic, orthopedic and
veterinary markets worldwide. In addition, Landec will periodically work with
market-leading companies to develop and commercialize differentiated
polymer-based products.For more information about the Company, visit Landec's
website at www.landec.com.

CONTACT: Landec Corporation
         Greg Skinner, 650-261-3677

company logo
 
Press spacebar to pause and continue. Press esc to stop.